Riccardo Ballarò

Senior Research Scientist

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Year:

2026

Year:

2025

Purpose: We conducted metabolomics and spatial cell transcriptomics of intraductal papillary mucinous neoplasms (IPMN), recognized pancreatic cancer precursors, to identify oncometabolites that inform upon risk of malignancy of IPMNs. Experimental Design: Untargeted metabolomic analyses were performed on cystic fluid from 125 patients with low-grade (LG) dysplasia or high-grade (HG) dysplasia with/without concurrent pancreatic ductal adenocarcinoma (PDAC; IPMN/PDAC). Predictive performance of individual metabolites for identifying HG or PDAC/IPMN was determined and compared with CA19-9 performance. Data were intersected with metabolic profiles of resected IPMN tissues and murine Kras;Gnas IPMN cell lines as well as spatial and single-cell transcriptomics of IPMNs. Results: A total of 388 metabolites were quantified in cystic fluid, of which 69 were differential ( P -value P -value P -value Conclusions: Cystic fluid polyamines offer utility for determining risk of malignancy of IPMNs that is complementary to CA19-9 and that has potential to aid in clinical management of patients with IPMNs.

Year:

2025

Supplemental Figure S7. Heatmap illustrating differences in gene-based signatures of immune cell types in epilesional (Epi), juxtalesional (Juxta), and perilesional (Peri) regions of high-grade (HG) and IPMN/PDAC compared to low-grade (LG) IPMN.

Year:

2025

Supplemental Figure S4. Scatter plots illustrating associations between cystic fluid spermidine, spermine, diacetylspermidine (DiAcSpmd), and acetylcadaverine (AcCad) [y-axis] and CA19-9 [x-axis].

Year:

2025

Exercise changes the tumor microenvironment by remodeling blood vessels and increasing infiltration by cytotoxic immune cells. The mechanisms driving these changes remain unclear. Herein, we demonstrate that exercise normalizes tumor vasculature and upregulates endothelial expression of VCAM1 in YUMMER 1.7 and B16F10 murine models of melanoma but differentially regulates tumor growth, hypoxia, and the immune response. We found that exercise suppressed tumor growth and increased CD8+ T-cell infiltration in YUMMER but not in B16F10 tumors. Single-cell RNA sequencing and flow cytometry revealed exercise modulated the number and phenotype of tumor-infiltrating CD8+ T cells and myeloid cells. Specifically, exercise caused a phenotypic shift in the tumor-associated macrophage population and increased the expression of major histocompatibility complex class II transcripts. We further demonstrated that ERK5 S496A knock-in mice, which are phosphorylation deficient at the S496 residue, ‘mimicked’ the exercise effect when unexercised, yet when exercised, these mice displayed a reversal in the effect of exercise on tumor growth and macrophage polarization compared to wild-type mice. Taken together, our results reveal tumor-specific differences in the immune response to exercise and show that ERK5 signaling via the S496 residue plays a crucial role in exercise-induced tumor microenvironment changes.

Year:

2024

Pancreatic Ductal Adenocarcinoma (PDAC) is characterized by high resistance to anti-cancer therapies. This resistance is caused in part by hypo-vascularization and dysfunctional vessels which inefficiently deliver chemotherapy. Here, we define the mechanism of aerobic exercise-induced tumor vascular remodeling and improved chemotherapy delivery and efficacy. We found that aerobic exercise was able to improve tumor vascular function and increase the number of lymphatic vessels, and these effects were associated with increased gemcitabine delivery to and efficacy against PDAC in mice. Further, exercise increased sphingosine-1-phosphate (S1P) in plasma and the activation of sphingosine-1-phosphate receptor 1 (S1PR1) in tumor endothelial cells. S1PR1 endothelial cell-specific deletion blunted the exercise-induced improvements in tumor vascular function, gemcitabine efficacy and drug concentration. Preclinical findings were validated in a patient cohort in which we found that exercise remodeled PDAC vasculature and improved tumor vascular function. These findings provide direct evidence that exercise increases chemotherapy delivery and efficacy by improving vascular function, defining S1PR1 as a necessary mediator of exercise-induced vascular remodeling.

Year:

2024

Year:

2023

Collaborators (19)

Jianjun Zhang

Professor

Indiana University Richard M Fairbanks School of Public Health

UNITED STATES
View details

Christian Maximillian Schmidt

Professor of Surgery

Indiana University School of Medicine

UNITED STATES
View details

Emily LaVoy

Associate Professor

University of Houston

UNITED STATES
View details

Keri Schadler

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Johannes Fahrmann

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ehsan Irajizad

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jennifer L. McQuade

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jody Vykoukal

Group Leader

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Guangyu Wang

Assistant Professor

Houston Methodist

UNITED STATES
View details

Samir M. Hanash

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jun-ichi Abe

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Rachelle Spencer

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

yihui chen

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Michele Yip-Schneider

Senior Research Professor

Indiana University School of Medicine

UNITED STATES
View details

Thais Bartelli

Research Investigator

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Kim‐Anh Do

-

UNITED STATES
View details

sivareddy kotla

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Anirban Maitra

Laura and Isaac Perlmutter Professor of Pathology

NYU Langone Health

UNITED STATES
View details

Masaki Imanishi

Associate Professor

Tokushima University

JAPAN
View details